Prognostic Factors Obtained from Long-Term Follow-up of Pituitary Adenomas and Other Sellar Tumors

被引:7
作者
Diri, Halit [1 ]
Ozaslan, Ersin [2 ]
Kurtsoy, Ali [3 ]
Tucer, Bulent [3 ]
Simsek, Yasin [1 ]
Ozturk, Figen [4 ]
Durak, Ahmet Candan [5 ]
Bayram, Fahri [1 ]
机构
[1] Erciyes Univ, Sch Med, Dept Endocrinol, Kayseri, Turkey
[2] Erciyes Univ, Sch Med, Dept Med Oncol, Kayseri, Turkey
[3] Erciyes Univ, Sch Med, Dept Neurosurg, Kayseri, Turkey
[4] Erciyes Univ, Sch Med, Dept Pathol, Kayseri, Turkey
[5] Erciyes Univ, Sch Med, Dept Radiol, Kayseri, Turkey
关键词
Pituitary adenoma; Sellar region tumor; Prognosis; Follow-up; TRANSSPHENOIDAL SURGERY; CRITERIA; MACROADENOMAS; EXPERIENCE; RECURRENT; REMOVAL;
D O I
10.5137/1019-5149.JTN.9140-13.1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
AIM: Pituitary adenomas do not have a single factor of aggressive behavior or recurrence. The objective of this study was to determine factors influencing the, prognosis in pituitary adenomas. MATERIAL and METHODS: 243 patients who were operated between January 2000 and June 2012 were included in this retrospective study. Demographic data, age at diagnosis, date of diagnosis, date of operation, type of operation, post-operative medications, pre- and postoperative hormone levels, and MRI findings were evaluated in each patient. RESULTS: The rate of total resection of sellar tumors was less than 50% in our patient population. The prognosis was better in cases with total resection. Tumor size was a poor prognostic factor in sellar tumors. Female sex was a poor prognostic factor in acromegaly and male sex in prolactinoma. The prognosis was worse in patients with cavernous sinus invasion. In acromegaly, pre-operative level of 850 ng/ml for IGF-1 was noted as a possible prognostic cut-off value. CONCLUSION: Long-term follow-up results of our study suggest that factors common to all sellar tumors including tumor type, tumor size, total resection, and cavernous sinus invasion and tumor type-specific factors including sex and hormone levels play important roles in the prognosis.
引用
收藏
页码:679 / 687
页数:9
相关论文
共 20 条
[1]   Endoscopic Endonasal Surgery in Recurrent and Residual Pituitary Adenomas After Microscopic Resection [J].
Alahmadi, Hussein ;
Dehdashti, Amir R. ;
Gentili, Fred .
WORLD NEUROSURGERY, 2012, 77 (3-4) :540-547
[2]   Gender-related Differences in Pituitary Adenomas [J].
Arasho, B. D. ;
Schaller, B. ;
Sandu, N. ;
Zenebe, G. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (10) :567-572
[3]  
Asa SL, 2008, ARCH PATHOL LAB MED, V132, P1231, DOI 10.1043/1543-2165(2008)132[1231:PPPWDT]2.0.CO
[4]  
2
[5]   Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly [J].
Beauregard, C ;
Truong, U ;
Hardy, J ;
Serri, O .
CLINICAL ENDOCRINOLOGY, 2003, 58 (01) :86-91
[6]   Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients [J].
Brochier, Sophie ;
Galland, Francoise ;
Kujas, Michele ;
Parker, Fabrice ;
Gaillard, Stephan ;
Raftopoulos, Christian ;
Young, Jacques ;
Alexopoulou, Orsalia ;
Maiter, Dominique ;
Chanson, Philippe .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 163 (02) :193-200
[7]   Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas [J].
Chang, Edward F. ;
Sughrue, Michael E. ;
Zada, Gabriel ;
Wilson, Charles B. ;
Blevins, Lewis S., Jr. ;
Kunwar, Sandeep .
PITUITARY, 2010, 13 (03) :223-229
[8]   Non-functioning pituitary adenomas:: clinical features and immunohistochemistry [J].
Ferreira, JEA ;
de Mello, PA ;
de Magalhaes, AV ;
Botelho, CHA ;
Naves, LA ;
Nosé, V ;
Schmitt, F .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (04) :1070-1078
[9]   Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth [J].
Greenman, Y ;
Ouaknine, G ;
Veshchev, I ;
Reider-Groswasser, II ;
Segev, Y ;
Stern, N .
CLINICAL ENDOCRINOLOGY, 2003, 58 (06) :763-769
[10]   Non-functioning pituitary adenomas [J].
Greenman, Yona ;
Stern, Naftali .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (05) :625-638